|
Stem cell based therapies raise high hope concerning the treatment of several human diseases. However, there still exists a great deal of social, economic and scientific uncertainty surrounding the use of stem cells, especially over the use of human embryonic stem cells. The recent development of induced pluripotent stem cells (iPS) bypass some of those critical issues by developing pluripotent stem cells customized to the patient, easy to produce and that does not require the use of embryos.
Several techniques have been developed and protected for the production of iPS cells such as the Thomson’s and Yamanaka’s techniques that have been published simultaneously. Indeed, since 2005, many new players (mainly institutional applicants) positioned on the thematic to bring their own brick to this technology. The setting up of winning patent strategies by existing actors and potential new entrants requires the ability to navigate accurately through the current patent landscape.
This patent landscape analysis on the field of “iPS cell generation” shows a boom of patent filings in this sector since 2007. Due to the youth of the technology, a majority of patent applications have been filed by institutional applicants such as the institutes of the historical inventors Shinya Yamanaka (
Kyoto
University - 25 filings), James Thomson (University of Wisconsin-Madison - 2 filings) or Rudolf Jaenisch (Whitehead Biomedical Institute – 7 filings). However several young companies have positioned themselves early on the thematic and have tried to set up interesting deals with well positioned institutional applicants such as iPierian that obtained non-exclusive worldwide rights from
Kyoto
University.
In this promising sector driven by potential important markets and where 244 patent families have been filed, this report “IP Overview – iPS Cell Generation –
2011” provides you with a comprehensive panorama of the intellectual property landscape and helps you:
- Position your company’s R&D and IP Portfolio
- Identify key inventors and key players involved in the generation of iPS cells
- Understand the collaboration networks and their dynamics
- Discover new trends and emerging topics
N.B.: A three months access to the full patent database is also included
|
